243 related articles for article (PubMed ID: 25676728)
1. Mutations in collagen, type XVII, alpha 1 (COL17A1) cause epithelial recurrent erosion dystrophy (ERED).
Jonsson F; Byström B; Davidson AE; Backman LJ; Kellgren TG; Tuft SJ; Koskela T; Rydén P; Sandgren O; Danielson P; Hardcastle AJ; Golovleva I
Hum Mutat; 2015 Apr; 36(4):463-73. PubMed ID: 25676728
[TBL] [Abstract][Full Text] [Related]
2. A COL17A1 Splice-Altering Mutation Is Prevalent in Inherited Recurrent Corneal Erosions.
Oliver VF; van Bysterveldt KA; Cadzow M; Steger B; Romano V; Markie D; Hewitt AW; Mackey DA; Willoughby CE; Sherwin T; Crosier PS; McGhee CN; Vincent AL
Ophthalmology; 2016 Apr; 123(4):709-22. PubMed ID: 26786512
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing and Segregation Analysis Confirms That a Mutation in COL17A1 Is the Cause of Epithelial Recurrent Erosion Dystrophy in a Large Dominant Pedigree Previously Mapped to Chromosome 10q23-q24.
Lin BR; Le DJ; Chen Y; Wang Q; Chung DD; Frausto RF; Croasdale C; Yee RW; Hejtmancik FJ; Aldave AJ
PLoS One; 2016; 11(6):e0157418. PubMed ID: 27309958
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Recurrent Erosion Dystrophy Secondary to COL17A1 c.3156C>T Mutation in a Non-white Family.
Vahedi F; Chung DD; Gee KM; Chuephanich P; Aldave AJ
Cornea; 2018 Jul; 37(7):909-911. PubMed ID: 29708937
[TBL] [Abstract][Full Text] [Related]
5. Epithelial recurrent erosion dystrophy (ERED) from the splice site altering COL17A1 variant c.3156C>T in families of Finnish-Swedish ancestry.
Turunen JA; Tuisku IS; Repo P; Mörtenhumer S; Kawan S; Järvinen RS; Korsbäck A; Immonen AT; Kivelä TT
Acta Ophthalmol; 2024 May; 102(3):296-305. PubMed ID: 37289141
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous
Hany U; Watson CM; Liu L; Smith CEL; Harfoush A; Poulter JA; Nikolopoulos G; Balmer R; Brown CJ; Patel A; Simmonds J; Charlton R; Acosta de Camargo MG; Rodd HD; Jafri H; Antanaviciute A; Moffat M; Al-Jawad M; Inglehearn CF; Mighell AJ
J Med Genet; 2024 Mar; 61(4):347-355. PubMed ID: 37979963
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
Kiritsi D; Kern JS; Schumann H; Kohlhase J; Has C; Bruckner-Tuderman L
J Med Genet; 2011 Jul; 48(7):450-7. PubMed ID: 21357940
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta.
Nakamura H; Sawamura D; Goto M; Nakamura H; Kida M; Ariga T; Sakiyama Y; Tomizawa K; Mitsui H; Tamaki K; Shimizu H
Int J Mol Med; 2006 Aug; 18(2):333-7. PubMed ID: 16820943
[TBL] [Abstract][Full Text] [Related]
10. Exclusion of the human collagen type XVII (COL17A1) gene as the cause of Thiel-Behnke corneal dystrophy (CDB2) on chromosome 10q23-q25.
Sullivan LS; Zhao X; Bowne SJ; Xu X; Daiger SP; Yee SB; Yee RW
Curr Eye Res; 2003 Oct; 27(4):223-6. PubMed ID: 14562173
[TBL] [Abstract][Full Text] [Related]
11. Autosomal dominant junctional epidermolysis bullosa.
Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
[TBL] [Abstract][Full Text] [Related]
12. Identification of A Novel
Chen AC; Niruthisard D; Chung DD; Chuephanich P; Aldave AJ
Ophthalmic Genet; 2020 Dec; 41(6):639-644. PubMed ID: 32880217
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic update of corneal dystrophies.
Lisch W; Weiss JS
Exp Eye Res; 2019 Sep; 186():107715. PubMed ID: 31301286
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing identifies double homozygous mutations in two distinct genes (EXPH5 and COL17A1) in a patient with concomitant simplex and junctional epidermolysis bullosa.
Vahidnezhad H; Youssefian L; Saeidian AH; Touati A; Sotoudeh S; Jazayeri A; Guy A; Lovell PA; Liu L; Kariminejad A; McGrath JA; Zeinali S; Uitto J
Hum Mutat; 2018 Oct; 39(10):1349-1354. PubMed ID: 30016581
[TBL] [Abstract][Full Text] [Related]
15. A Silent COL17A1 Variant Alters Splicing and Causes Junctional Epidermolysis Bullosa.
Hoffmann J; Casetti F; Reimer A; Leppert J; Grüninger G; Has C
Acta Derm Venereol; 2019 Apr; 99(4):460-461. PubMed ID: 30673110
[No Abstract] [Full Text] [Related]
16. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands.
Pasmooij AM; Pas HH; Jansen GH; Lemmink HH; Jonkman MF
Br J Dermatol; 2007 May; 156(5):861-70. PubMed ID: 17263807
[TBL] [Abstract][Full Text] [Related]
17. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations.
Pasmooij AM; Nijenhuis M; Brander R; Jonkman MF
J Invest Dermatol; 2012 May; 132(5):1374-83. PubMed ID: 22318390
[TBL] [Abstract][Full Text] [Related]
18. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
Darling TN; Yee C; Koh B; McGrath JA; Bauer JW; Uitto J; Hintner H; Yancey KB
J Invest Dermatol; 1998 Feb; 110(2):165-9. PubMed ID: 9457913
[TBL] [Abstract][Full Text] [Related]
19. Amino acid duplication in the coiled-coil structure of collagen XVII alters its maturation and trimerization causing mild junctional epidermolysis bullosa.
Kroeger JK; Hofmann SC; Leppert J; Has C; Franzke CW
Hum Mol Genet; 2017 Feb; 26(3):479-488. PubMed ID: 28365758
[TBL] [Abstract][Full Text] [Related]
20. Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen.
Pasmooij AM; van der Steege G; Pas HH; Smitt JH; Nijenhuis AM; Zuiderveen J; Jonkman MF
Br J Dermatol; 2004 Sep; 151(3):669-74. PubMed ID: 15377356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
